| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-938-30 | 65862-938 | HUMAN PRESCRIPTION DRUG | Paricalcitol | Paricalcitol | CAPSULE, LIQUID FILLED | ORAL | 20160114 | N/A | ANDA | ANDA207672 | Aurobindo Pharma Limited | PARICALCITOL | 4 ug/1 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-938-30) |
| 65862-937-30 | 65862-937 | HUMAN PRESCRIPTION DRUG | Paricalcitol | Paricalcitol | CAPSULE, LIQUID FILLED | ORAL | 20160114 | N/A | ANDA | ANDA207672 | Aurobindo Pharma Limited | PARICALCITOL | 2 ug/1 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-937-30) |
| 65862-936-30 | 65862-936 | HUMAN PRESCRIPTION DRUG | Paricalcitol | Paricalcitol | CAPSULE, LIQUID FILLED | ORAL | 20160114 | N/A | ANDA | ANDA207672 | Aurobindo Pharma Limited | PARICALCITOL | 1 ug/1 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-936-30) |